Klaudia Kosowska-Shick

1.3k total citations
35 papers, 1.1k citations indexed

About

Klaudia Kosowska-Shick is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Klaudia Kosowska-Shick has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 15 papers in Epidemiology and 13 papers in Pharmacology. Recurrent topics in Klaudia Kosowska-Shick's work include Antimicrobial Resistance in Staphylococcus (25 papers), Pneumonia and Respiratory Infections (14 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). Klaudia Kosowska-Shick is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (25 papers), Pneumonia and Respiratory Infections (14 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). Klaudia Kosowska-Shick collaborates with scholars based in United States, Belgium and Poland. Klaudia Kosowska-Shick's co-authors include Peter C. Appelbaum, Pamela McGhee, Catherine Clark, Bonifacio Dewasse, Glenn A. Pankuch, Kim Credito, Tatiana Bogdanovich, Lois M. Ednie, Kathleen G. Julian and Françoise Van Bambeke and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Klaudia Kosowska-Shick

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaudia Kosowska-Shick United States 19 708 380 325 320 278 35 1.1k
Céline Vidaillac United States 20 601 0.8× 382 1.0× 357 1.1× 354 1.1× 225 0.8× 43 1.2k
Bret M. Benton United States 18 677 1.0× 590 1.6× 338 1.0× 262 0.8× 246 0.9× 25 1.3k
Pamela McGhee United States 14 454 0.6× 199 0.5× 286 0.9× 248 0.8× 222 0.8× 26 760
Jeffrey B. Locke United States 21 1.1k 1.5× 538 1.4× 259 0.8× 275 0.9× 438 1.6× 45 1.7k
James E. Ross United States 22 978 1.4× 450 1.2× 189 0.6× 345 1.1× 211 0.8× 40 1.3k
Steve N. Leonard United States 11 499 0.7× 458 1.2× 162 0.5× 229 0.7× 114 0.4× 11 937
Donald Biek United States 17 534 0.8× 339 0.9× 287 0.9× 212 0.7× 284 1.0× 26 966
J.I. Ross United Kingdom 15 610 0.9× 382 1.0× 131 0.4× 335 1.0× 341 1.2× 16 1.5k
M Konno Japan 12 959 1.4× 727 1.9× 328 1.0× 602 1.9× 277 1.0× 18 1.6k
Tatiana Bogdanovich United States 17 391 0.6× 237 0.6× 278 0.9× 522 1.6× 275 1.0× 27 1.1k

Countries citing papers authored by Klaudia Kosowska-Shick

Since Specialization
Citations

This map shows the geographic impact of Klaudia Kosowska-Shick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaudia Kosowska-Shick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaudia Kosowska-Shick more than expected).

Fields of papers citing papers by Klaudia Kosowska-Shick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaudia Kosowska-Shick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaudia Kosowska-Shick. The network helps show where Klaudia Kosowska-Shick may publish in the future.

Co-authorship network of co-authors of Klaudia Kosowska-Shick

This figure shows the co-authorship network connecting the top 25 collaborators of Klaudia Kosowska-Shick. A scholar is included among the top collaborators of Klaudia Kosowska-Shick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaudia Kosowska-Shick. Klaudia Kosowska-Shick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Gengrong, Glenn A. Pankuch, Peter C. Appelbaum, & Klaudia Kosowska-Shick. (2012). Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill. Diagnostic Microbiology and Infectious Disease. 73(3). 287–289. 8 indexed citations
2.
Mendes, Rodrigo E., Athanasios Tsakris, Hélio S. Sader, et al.. (2012). Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. Journal of Antimicrobial Chemotherapy. 67(6). 1321–1324. 80 indexed citations
4.
Pankuch, Glenn A., et al.. (2011). Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 55(5). 2463–2465. 18 indexed citations
5.
Kosowska-Shick, Klaudia, Pamela McGhee, & Peter C. Appelbaum. (2010). Affinity of Ceftaroline and Other β-Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 54(5). 1670–1677. 148 indexed citations
6.
Kosowska-Shick, Klaudia, Kathleen G. Julian, Pamela McGhee, Peter C. Appelbaum, & Cynthia Whitener. (2010). Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital. Diagnostic Microbiology and Infectious Disease. 68(1). 34–39. 23 indexed citations
7.
Lemaire, Sandrine, Klaudia Kosowska-Shick, Peter C. Appelbaum, et al.. (2010). Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint. Journal of Antimicrobial Chemotherapy. 66(3). 596–607. 32 indexed citations
8.
Credito, Kim, Klaudia Kosowska-Shick, Pamela McGhee, Glenn A. Pankuch, & Peter C. Appelbaum. (2009). Comparative Study of the Mutant Prevention Concentrations of Moxifloxacin, Levofloxacin, and Gemifloxacin against Pneumococci. Antimicrobial Agents and Chemotherapy. 54(2). 673–677. 10 indexed citations
9.
McGhee, Pamela, Catherine Clark, Klaudia Kosowska-Shick, et al.. (2009). In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms. Antimicrobial Agents and Chemotherapy. 54(1). 230–238. 55 indexed citations
11.
Kosowska-Shick, Klaudia. (2008). Molecular and Epidemiological Characteristics of Linezolid-Resistant Coagulase-Negative Staphylococci at a Tertiary Care Hospital. 46th Annual Meeting. 1 indexed citations
12.
Sabat, Artur J., Benedykt Władyka, Klaudia Kosowska-Shick, et al.. (2008). Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureusstrains. BMC Microbiology. 8(1). 129–129. 19 indexed citations
13.
Lemaire, Sandrine, Klaudia Kosowska-Shick, Kathleen G. Julian, et al.. (2008). Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis. Clinical Microbiology and Infection. 14(8). 766–777. 29 indexed citations
14.
Kosowska-Shick, Klaudia, Hiroyasu Koga, Kenji Masunaga, et al.. (2007). Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones. Diagnostic Microbiology and Infectious Disease. 62(1). 16–22. 2 indexed citations
15.
Julian, Kathleen G., Klaudia Kosowska-Shick, Cynthia Whitener, et al.. (2007). Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis. Antimicrobial Agents and Chemotherapy. 51(9). 3445–3448. 106 indexed citations
16.
Clark, Catherine L., Klaudia Kosowska-Shick, Lois M. Ednie, & Peter C. Appelbaum. (2007). Capability of 11 Antipneumococcal Antibiotics To Select for Resistance by Multistep and Single-Step Methodologies. Antimicrobial Agents and Chemotherapy. 51(11). 4196–4201. 8 indexed citations
17.
Bogdanovich, Tatiana, Catherine Clark, Klaudia Kosowska-Shick, et al.. (2007). Antistaphylococcal Activity of CG400549, a New Experimental FabI Inhibitor, Compared with That of Other Agents. Antimicrobial Agents and Chemotherapy. 51(11). 4191–4195. 17 indexed citations
18.
Kosowska-Shick, Klaudia, Catherine Clark, Kim Credito, et al.. (2006). Single- and Multistep Resistance Selection Studies on the Activity of Retapamulin Compared to Other Agents against Staphylococcus aureus and Streptococcus pyogenes. Antimicrobial Agents and Chemotherapy. 50(2). 765–769. 66 indexed citations
19.
Kosowska-Shick, Klaudia, Kathy Smith, Tatiana Bogdanovich, et al.. (2006). Activity of DX-619 Compared to Other Agents against Viridans Group Streptococci, Streptococcus bovis , and Cardiobacterium hominis. Antimicrobial Agents and Chemotherapy. 50(12). 4191–4194. 1 indexed citations
20.
Stratchounski, L., et al.. (2006). Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre study. Clinical Microbiology and Infection. 12(9). 853–866. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026